Most cerebellar granule neurons in weaver mice undergo premature apoptosis during the first 3 postnatal weeks, subsequently leading to severe
ataxia. The death of these granule neurons appears to result from a point mutation in the GIRK2 gene, which encodes a
G protein-activated, inwardly rectifying K+ channel
protein. Although the genetic defect was identified, the molecular mechanism by which the mutant K+ channel selectively attacks granule neurons in weaver mice is unclear. Before their demise, weaver granule neurons express abnormally high levels of
insulin-like growth factor (
IGF) binding protein 5 (IGFBP5).
IGF-I is essential for the survival of cerebellar neurons during their differentiation. Because IGFBP5 has the capacity to block
IGF-I activity, we hypothesized that reduced
IGF-I availability resulting from excess IGFBP5 accelerates the apoptosis of weaver granule neurons. We found that, consistently with this hypothesis, exogenous
IGF-I partially protected cultured weaver granule neurons from apoptosis by activating Akt and decreasing
caspase-3 activity. To determine whether
IGF-I protects granule neurons in vivo, we cross-bred weaver mice with transgenic mice that overexpress
IGF-I in the cerebellum. The cerebellar volume was increased in weaver mice carrying the
IGF-I transgene, predominantly because of an increased number of surviving granule neurons. The presence of the
IGF-I transgene resulted in improved muscle strength and a reduction in
ataxia, indicating that the surviving granule neurons are functionally integrated into the cerebellar neuronal circuitry. These results confirm our previous suggestion that a lack of
IGF-I activity contributes to apoptosis of weaver granule neurons in vivo and supports
IGF-I's potential
therapeutic use in
neurodegenerative disease.